Author(s): Parson A
Abstract Share this page
Abstract There is much interest in developing stem cells and the cells derived from them as therapies for treating human disease and injury, but many biological, technological and regulatory hurdles have to be overcome before these cell therapies can be brought to commercial fruition.
This article was published in Cell
and referenced in Journal of Stem Cell Research & Therapy